Perbedaan Ifishdeco Tbk. dan Organon Pharma Indonesia Tbk.: Ifishdeco Tbk. diperdagangkan di Rp1.075 (kapitalisasi pasar 2,3 T, volume 24 jam 200), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Ifishdeco Tbk. jauh lebih besar — sekitar 22× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| IFSH | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 2,3 T | 104,4 M |
Volume | 200 | — |
Lot | 2 | — |
Perputaran | 215 rb | — |
Harga Rata-rata | 1.075 | — |
Nilai Transaksi | 215 rb | — |
Harga Ekuilibrium Indikatif | 1.075 | — |
Volume Ekuilibrium Indikatif | 3 | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Ifishdeco Tbk (the Entity) was established within the framework of the Indonesia Domestic Capital Investment Law No.6 year 1968 juncto law No.12 year 1970, based on Notarial deed No. 41 dated June 9, 1971 by Abdul Latief, S.H., notary in Jakarta.
Selengkapnya di halaman IFSH →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →